课题基金 / 基金详情

NEW TREATMENT FOR PULMONAY HYPERTENSION

NEW TREATMENT FOR PULMONAY HYPERTENSION
肺动脉高压的新疗法
批准号:
14370234
负责人:
IMAIZUMI Tsutomu
金额:
$9.41万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2004

项目摘要

项目成果

IMAIZUMI Tsutomu的其他基金

相似基金

相关文献

中文摘要
翻译
(1)野百合碱注射后1周和4周,每隔7天向大鼠股肌肉注射编码前列环素合成酶(PGIS)基因的裸质粒。PGIS基因转移增加了肌肉内和血清中6-酮-前列腺素F2-α,前列环素的稳定代谢物。在野百合碱治疗的大鼠中,重复的PGIS基因转移显著降低了肺动脉压,改善了右室肥厚和肺动脉重塑。在正常大鼠中,3%的骨髓来源的单个核细胞(BM-MNCs)在细胞移植后1d聚集在肺内。细胞移植2周后,仅有1%的BM-MNCs在肺内检测到。通过逆转录病毒载体介导的PGIs基因转移,建立了高表达PGIs基因并产生前列环素的BM-MNC系。(4)高表达PGIs基因的BM-MNC移植显著降低了肺动脉高压大鼠的肺动脉压,改善了右室肥厚。
英文摘要
(1)Naked plasmid encoding the prostacyclin synthase (PGIS) gene was injected into the thigh muscle every 7 days from 1 week and 4weeks after monocrotaline injection in rats. PGIS gene transfer increased intramuscular and serum 6-keto-prostaglandin F2-alpha, a stable metabolite of prostacyclin. Repeated PGIS gene transfers significantly reduced pulmonary arterial pressure and ameliorated right ventricular hypertrophy and pulmonary arterial remodeling in monocrotaline-treated rats. Furthermore, survival rate was significantly improved by repeated PGIS gene transfers.(2)In normal rats, 3% of intravenously implanted bone marrow-derived mononuclear cells (BM-MNCs) accumulated in the lung 1 day after cell transplantation. Two weeks after cell transplantation, only 1 % of tranplnted BM-MNCs were detected in the lung. In contrast, the rate of lung distribution of transplanted BM-MNCs were remarkably increased in monocrotalin-induced pulmonary hypertension rats (10% and 6% at days 1 and 14, respectively).(3)We established BM-MNC line, which overexpresses PGIS gene and produces prostacyclin, by using a retroviral vector-mediated gene transfer of PGIS.(4)Transplantation of PGIS-overexpressing BM-MNCs significantly reduced pulmonary arterial pressure and ameliorated right ventricular hypertrophy in monocrotaline-induced pulmonary hypertension rats.
期刊论文(22)
专著(0)
科研奖励(0)
会议论文
Roles of endogenous monocyate chemoattractant protein-1 in ischemia-induced neovascularization.
内源性单氰酸趋化蛋白-1 在缺血诱导的新血管形成中的作用。
DOI: --
发表时间: 2004
期刊: J Am Coll Cardiol 44
影响因子: --
作者: [Niiyama H, Kai H, Yamamoto T, Shimada T, Sasaki K, Murohara T, Egashira K, Imaizumi T]
通讯作者: Imaizumi T
Advanced glycation end products activate mesangial TGF-β-Smad signaling via angiotensin II-type I receptor interaction.
晚期糖基化终末产物通过血管紧张素 II-I 型受体相互作用激活系膜 TGF-β-Smad 信号传导。
DOI: --
发表时间: 2004
期刊: Kidny Int 66
影响因子: --
作者: [Fukami K, Ueda S, Yamagishi S, Kato S, Inagaki Y, Takeuchi M, Motoyama Y, Bucala R, Iida S, Tamaki K, Imaizumi T, Cooper EM, Okuda S]
通讯作者: Okuda S
DOI: 10.1172/jci16645
发表时间: 2003-07
期刊: The Journal of clinical investigation
影响因子: --
作者: [K. Egami;T. Murohara;Toshifumi Shimada;Ken-ichiro Sasaki;Satoshi Shintani;T. Sugaya;M. Ishii;T. Akagi]
通讯作者: K. Egami;T. Murohara;Toshifumi Shimada;Ken-ichiro Sasaki;Satoshi Shintani;T. Sugaya;M. Ishii;T. Akagi
Shibata R, Imaizumi T(他6名, 8番目): "Inhibition of STAT3 prevents neointima formation by inhibiting proliferation and promoting apoptosis of neointimal smooth muscle cell"Human Gene Ther. 14(7). 601-610 (2003)
Shibata R、Imaizumi T(其他 6 人,第 8):“抑制 STAT3 通过抑制增殖和促进新内膜平滑肌细胞凋亡来预防新内膜形成”Human Gene Ther 14(7) (2003)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 10 条
    Mechanism of Endothelial Dysfunction in Chronic Kidney Disease
    • 批准号:
      21390249
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.4万
    • 财政年份:
      2009
    • 负责人:
      IMAIZUMI Tsutomu
    • 依托单位:
    Role of brain nitric oxide in the development of experimental hypertension.
    • 批准号:
      08457217
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $1.79万
    • 财政年份:
      1995
    • 负责人:
      IMAIZUMI Tsutomu
    • 依托单位:
    Effects of Insulin on sympethetic tone
    海外基金